Takotsubo cardiomyopathy Afatinib-related in a non-small cell lung cancer patient: Case report
German E. Ramos(Fundación Arturo López Pérez), Manuel E. Rodríguez(Fundación Arturo López Pérez), Mario I. Zapata(Fundación Arturo López Pérez), Sergio E. Panay(Fundación Arturo López Pérez), Juan Francisco Bulnes(Pontificia Universidad Católica de Chile), Andrés J. Daniele(Asociación por los Derechos Civiles), Christian Caglevic
Cited by 8
Related Papers
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
|The Lancet|2018|1.3k
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2021|645
Cardiovascular Manifestations From Therapeutic Radiation
|JACC CardioOncology|2021|201
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon
|Advances in experimental medicine and biology|2017|143